Global Anti-Infective Agents Market Size study, by Type/Drug Class, by Route of Administration, by Distribution Channel and Regional Forecasts 2022-2032

Description

The Global Anti-Infective Agents market was valued at approximately USD 136.9 billion in 2023 and is projected to experience a modest growth rate with a CAGR of 1.2% over the forecast period from 2024 to 2032. Anti-infective agents, encompassing antibiotics, antivirals, antifungals, and antiparasitics, play a pivotal role in both human and veterinary medicine by preventing and treating infections caused by various microorganisms. These agents are critical in the management of diseases such as bacterial pneumonia, HIV, fungal infections, and malaria, and are indispensable in surgical procedures and for immunocompromised patients to prevent infections. Beyond healthcare, anti-infective agents are utilized in agriculture to protect plants from pathogens and in sanitation products to maintain hygiene.

The market's growth is significantly driven by the rising prevalence of infectious diseases, including the COVID-19 pandemic, tuberculosis, and malaria, which necessitate effective treatments to manage outbreaks and prevent pandemics. Furthermore, the escalating issue of antibiotic resistance underscores the urgent need for innovative anti-infective agents. Pharmaceutical companies and research institutions are investing heavily in developing new drugs to combat resistant strains, supported by global health initiatives targeting antibiotic resistance as a critical public health threat. Advancements in drug development technologies, such as genomics, proteomics, and bioinformatics, have facilitated the creation of novel anti-infective agents with improved efficacy and reduced side effects. These technological strides are attracting significant investment and fostering market expansion. Also, Emerging markets, particularly in Asia, Africa, and Latin America, present substantial growth opportunities due to increasing healthcare expenditure and improving access to healthcare services. Pharmaceutical companies are expanding their presence in these regions to capitalize on the growing demand for healthcare solutions. Additionally, innovations in biotechnology, including the development of biologics and biosimilars, are opening new avenues for the anti-infective agents market, offering more effective treatments and diversification opportunities. However, the market faces challenges such as stringent regulatory requirements, which can delay the introduction of new products. The complex and time-consuming approval process, coupled with the high cost of compliance, can be a significant barrier, particularly for smaller companies.

North America dominated the market in 2023, accounting for the largest share of 37.0% of the overall revenue. The region's sophisticated healthcare infrastructure, increasing awareness among healthcare professionals, and strong government emphasis on public health initiatives drive market growth. The Asia Pacific region is projected to expand at the fastest growth rate of 3.7% during the forecast period, driven by the presence of generic companies, rising economic stability, increasing disposable income levels, and a growing aging population susceptible to infections.

Major market players included in this report are:

Pfizer Inc.
Abbott
Gilead Sciences, Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc.
Sandoz International GmbH
B. Braun SE
Xellia Pharmaceuticals
Mankind Pharma
Bayer AG
AstraZeneca
Boehringer Ingelheim International GmbH
GlaxoSmithKline plc
Novartis AG
Johnson & Johnson

The detailed segments and sub-segment of the market are explained below:

By Type/Drug Class:

Antibacterials
Antivirals
Antifungals

By Route of Administration:

Topical
Oral
IV
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies
E-Commerce
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows: Historical year - 2022 Base year - 2023 Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Anti-Infective Agents Market Executive Summary

1.1. Global Anti-Infective Agents Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type/Drug Class
- 1.3.2. By Route of Administration
- 1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Anti-Infective Agents Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Anti-Infective Agents Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Prevalence of Infectious Diseases
- 3.1.2. Antibiotic Resistance
- 3.1.3. Advancements in Drug Development
3.2. Market Challenges
- 3.2.1. Regulatory Hurdles
- 3.2.2. High Cost of Pathology Instruments and Services
3.3. Market Opportunities
- 3.3.1. Expansion in Emerging Markets
- 3.3.2. Biotechnology Innovations

Chapter 4. Global Anti-Infective Agents Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Anti-Infective Agents Market Size & Forecasts by Type/Drug Class 2022-2032

5.1. Segment Dashboard
5.2. Global Anti-Infective Agents Market: Type/Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Antibacterials
- 5.2.2. Antivirals
- 5.2.3. Antifungals

Chapter 6. Global Anti-Infective Agents Market Size & Forecasts by Route of Administration 2022-2032

6.1. Segment Dashboard
6.2. Global Anti-Infective Agents Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Topical
- 6.2.2. Oral
- 6.2.3. IV
- 6.2.4. Others

Chapter 7. Global Anti-Infective Agents Market Size & Forecasts by Distribution Channel 2022-2032

7.1. Segment Dashboard
7.2. Global Anti-Infective Agents Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Hospital Pharmacies
- 7.2.2. Retail Pharmacies
- 7.2.3. Specialty Pharmacies
- 7.2.4. E-Commerce
- 7.2.5. Others

Chapter 8. Global Anti-Infective Agents Market Size & Forecasts by Region 2022-2032

8.1. North America Anti-Infective Agents Market
- 8.1.1. U.S. Anti-Infective Agents Market
  - 8.1.1.1. Type/Drug Class breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Route of Administration breakdown size & forecasts, 2022-2032
  - 8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Anti-Infective Agents Market
8.2. Europe Anti-Infective Agents Market
- 8.2.1. U.K. Anti-Infective Agents Market
- 8.2.2. Germany Anti-Infective Agents Market
- 8.2.3. France Anti-Infective Agents Market
- 8.2.4. Spain Anti-Infective Agents Market
- 8.2.5. Italy Anti-Infective Agents Market
- 8.2.6. Rest of Europe Anti-Infective Agents Market
8.3. Asia-Pacific Anti-Infective Agents Market
- 8.3.1. China Anti-Infective Agents Market
- 8.3.2. India Anti-Infective Agents Market
- 8.3.3. Japan Anti-Infective Agents Market
- 8.3.4. Australia Anti-Infective Agents Market
- 8.3.5. South Korea Anti-Infective Agents Market
- 8.3.6. Rest of Asia Pacific Anti-Infective Agents Market
8.4. Latin America Anti-Infective Agents Market
- 8.4.1. Brazil Anti-Infective Agents Market
- 8.4.2. Mexico Anti-Infective Agents Market
- 8.4.3. Rest of Latin America Anti-Infective Agents Market
8.5. Middle East & Africa Anti-Infective Agents Market
- 8.5.1. Saudi Arabia Anti-Infective Agents Market
- 8.5.2. South Africa Anti-Infective Agents Market
- 8.5.3. Rest of Middle East & Africa Anti-Infective Agents Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Pfizer Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Abbott
- 9.3.3. Gilead Sciences, Inc.
- 9.3.4. Bristol-Myers Squibb Company
- 9.3.5. Merck & Co., Inc.
- 9.3.6. Sandoz International GmbH
- 9.3.7. B. Braun SE
- 9.3.8. Xellia Pharmaceuticals
- 9.3.9. Mankind Pharma
- 9.3.10. Bayer AG

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes